Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

U.S. Atherectomy and Thrombectomy Devices Market - Expansion into underserved indications enables market growth for cutting edge Thrombectomy and Atherectomy devices
U.S. Atherectomy and Thrombectomy Devices Market


PRZOOM - /newswire/ - Palo Alto, CA, United States, 2006/10/19 - Expansion into underserved indications enables market growth for cutting edge Thrombectomy and Atherectomy devices.

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


While physicians might differentiate between the various blood vessel anatomies, lipids and platelets do not. Occlusions in the coronary arteries are usually accompanied by at-risk build-ups in the peripheral vasculature as well. More than 50 percent of patients with arterial diseases fail to show a reduction in disease progression with pharmaceutical therapy alone. More than 40 percent of arterial disease patients are not candidates for risky by-pass procedures. Minimally invasive catheter interventions reduces procedure times, recovery time, and have overall higher clinical rates of success. Advances in catheter technology and cardiovascular imaging techniques are spurring thrombectomy and atherectomy device usage.
New analysis from Frost & Sullivan, U.S. Atherectomy and Thrombectomy Devices Market, reveals that revenues in this market totaled $266.2 million in 2005, and can reach $863.8 million in 2012.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Atherectomy and Thrombectomy Devices Market then send an e-mail to Melina Trevino - Corporate Communications at melina.trevino[.] with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

“The peripheral market is seen as the next major growth opportunity for market participants in the cardiovascular arena, and its vast potential is attracting competitors from all levels of the medical device industry,” notes Frost & Sullivan Industry Analyst Venkat Rajan. “In the United States, each year, an estimated 175,000 bypass procedures and 160,000 amputations are performed as a result of advanced stage peripheral vascular disease. Advanced detection and preventative measures such as atherectomy and thrombectomy procedures could reduce the percentage of patients requiring amputation by 80 percent.”

Advances in imaging, navigation, and catheter capabilities are a crucial driver for expanding atherectomy and thrombectomy device usage. Technological advances such as on-board imaging capabilities or localized drug delivery could be a major component of future device offerings.

A major concern preventing the full-scale usage of atherectomy and thrombectomy devices is the inherent safety issues attached to them. Since each of these devices uses some sort of force to remove or destroy obstructions, there exists the risk of causing blunt trauma to the vessel walls. Any sort of trauma can lead to weakening of vessels, possible rupture, or scar formation resulting in collateral damage.

“Occlusions in delicate regions such as the cerebral vasculature had been previously been un-addressable,” notes Rajan. “Furthermore clinical data itself is no longer taken simply at face value, and a number of clinicians in addition to the actual devices evaluate the thoroughness of the trial itself.”

In order to overcome these challenges, market participants could make greater use of head-to-head clinical trial data. Additional strategies involve grass roots marketing techniques to help establish market foothold, and deferred capital equipment costs to incentivize adoption. As in other markets direct to patient marketing is helping expand the general knowledge of available treatment options capable of addressing advanced cardiovascular diseases.

U.S. Atherectomy and Thrombectomy Devices Market is part of the Medical Device Subscription, which also includes research in the following markets: U.S. Carotid and Intracranial Devices, U.S. Angioplasty and Vascular Closure Markets, and the U.S. Peripheral Stent and Stent Grafts Market. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews are available to the press.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+]

# # #
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!

U.S. Atherectomy and Thrombectomy Devices Market

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Contact: Melina Trevino 
210.247.2440 melina.trevino[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From Frost & Sullivan / Company Profile

Read Medical Services/Equipment Most Recent Related Press Releases:

Frost & Sullivan Recognizes Acelity as a Leader in the Field with its New V.A.C.ULTA™ 4 Therapy System and V.A.C. VERAFLO CLEANSE CHOICE™ Dressing
Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...


Visit  La Bella Bakery Artisan Bakery Arizona


Visit  SKS Media | SKS Associates Ltd

  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today